November 5, 2010
9:00 A.M. - 6:00 P.M.
UC Davis School of Law
Ongoing improvements in DNA sequencing technology and the increasing availability of bio-banked materials are converging to create advanced personalized medicine diagnostics and treatments that offer the promise of improved outcomes and lower healthcare costs. Fenwick & West and UC Davis School of Law will host a panel of distinguished experts to discuss an array of issues and challenges in the emerging field of personalized medicine. Symposium topics will focus on issues and challenges arising from recent developments that call into question the scope of patent protection available to support investment in this nascent industry as well as issues regarding ownership and licensing of related technology and information; the potential impact of direct to health care consumers offers of genetic tests and other personalized medicine services; and the entrepreneurial environment for personalized medicine in the evolving health care economy. Professionals, entrepreneurs, executives and students in law, medicine, management and other related fields are invited to attend this important symposium to garner knowledge that will synthesize current developments and anticipate future directions along the road to translating the promise of personalized medicine into an emerging, new reality.
MCLE credits available.
Program Details
The order and timing of the panels is subject to change.
8:45 A.M. - 9:30 A.M.
Continental Breakfast & Registration
UC Davis School of Law, King Hall
Main Lobby
9:30 A.M. - 9:45 A.M.
Welcome
Kalmanovitz Appellate Courtroom (room 1001), King Hall, UC Davis
Speakers:
- Kevin R. Johnson, Dean and Mabie-Apallas Professor of Public Interest Law and Chicana/o Studies, UC Davis School of Law
- David Bell, Partner, Fenwick & West
9:45 A.M. - 10:15 A.M.
Introduction to Personalized Medicine
Kalmanovitz Appellate Courtroom (room 1001), King Hall, UC Davis
Speaker: George Schreiner, MD, PhD, Chairman of Board, PROOF Center of Excellence, in affiliation with University of British Columbia, CEO, Cardero Therapeutics
10:30 A.M. - 11:45 A.M.
Panel I: From the Lab to the Patient: Intellectual Property in Personalized Medicine
1 MCLE credit
Kalmanovitz Appellate Courtroom (room 1001), King Hall, UC Davis
Moderator: Peter Lee, Professor of Law, UC Davis School of Law
Panelists:
- Barbara Brenner, Executive Director, Breast Cancer Action
- Mark Capone, President, Myriad Genetic Laboratories
- Clinton Neagley, Associate Director, UC Davis InnovationAccess – Technology Transfer Services
- Michael Shuster, Partner, Fenwick & West
Noon – 1:30 P.M.
Lunch and Keynote Presentation
UC Davis Conference Center
Speaker: Kathryn Lowell, California Deputy Secretary for Life Sciences and Health Systems
Luncheon is $25 per person, $15 per student
Limited Seating
Please RSVP by Friday, October 29
1:45 P.M. - 3:00 P.M.
Panel II: Issues for Entrepreneurs in the Nascent Industry
1 MCLE credit
Kalmanovitz Appellate Courtroom (room 1001), King Hall, UC Davis
Moderator: Stephen Graham, Partner, Fenwick & West
Panelists:
3:15 P.M. – 4:45 P.M.
Panel III: Consumers in the New Personalized Medicine Model
1 MCLE credit
Kalmanovitz Appellate Courtroom (room 1001), King Hall, UC Davis
Moderator: Lisa Ikemoto, Professor at Law, UC Davis School of Law
Panelists:
- Sandra Soo-Jin Lee, Ph.D., Center for Biomedical Ethics, Stanford Medical School
- Ed MacBean, Product Management Vice President, Pathway Genomics
- Beatrice O’Keefe, Laboratory Field Services, Department of Public Health
- Michael Wilkes, Vice Dean of the School of Medicine and Director of Global Health, UC Davis Health Systems
4:45 P.M. - 4:50 P.M.
Closing Remarks
Kalmanovitz Appellate Courtroom (room 1001), King Hall, UC Davis
Reception Immediately Following
